Company Name or Ticker Symbol
Search for other Categories

Acadia Pharmaceuticals Inc  (ACAD)
Other Ticker:  
    Sector  Healthcare    Industry Major Pharmaceutical Preparations

ACAD's Revenue Year on Year Growth by Quarter and Year

Acadia Pharmaceuticals Inc's Revenue results by quarter and year

Select the Comparisons : Select the Ratio:                        
ACAD Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 17.19 0.04 0.02
III Quarter September - 0.10 - 0.03
II Quarter June - - - 0.03
I Quarter March 15.29 0.02 0.05 -3.02
FY   15.29 17.31 0.09 -2.94

Financial Statements
Acadia Pharmaceuticals Inc's first quarter 2017 Revenue $ 15.29 millions ACAD's Income Statement
Acadia Pharmaceuticals Inc's first quarter 2016 Revenue $ 0.02 millions Quarterly ACAD's Income Statement
ACAD's Growth by Division See ACAD's Growth by Segment

ACAD Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 42875 % 100 % -91.67 %
III Quarter September - - - -93.33 %
II Quarter June - - - -92.11 %
I Quarter March 76330 % -60 % - -
FY   - 19133.33 % - -

ACAD Revenue Growth Comment
Acadia Pharmaceuticals Inc achieved in the first quarter, above Company average Revenue surge of 76330% year on year, to $ 15.29 millions.

According to the results reported in the first quarter, Acadia Pharmaceuticals Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Acadia Pharmaceuticals Inc' s Revenue doubling of 76330% ranks overall at the positon no. 4 in the first quarter.

Revenue Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #1
S&P 500 #4
Revenue Y/Y Growth Statistics
High Average Low
382050 % 41023.44 % -96.43 %
(Mar 31 2017)   (Jun 30 2015)

You need to upgrade your Flash Player

Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ACAD's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ACAD's Competitors
Revenue Growth for Acadia Pharmaceuticals Inc's Suppliers
Revenue Growth for ACAD's Customers

You may also want to know
ACAD's Annual Growth Rates ACAD's Profitability Ratios ACAD's Asset Turnover Ratio ACAD's Dividend Growth
ACAD's Roe ACAD's Valuation Ratios ACAD's Financial Strength Ratios ACAD's Dividend Payout Ratio
ACAD's Roa ACAD's Inventory Turnover Ratio ACAD's Growth Rates ACAD's Dividend Comparisons

Companies with similar Revenue doubling for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Second Sight Medical Products Inc  95,721.46 %$ 95,721.462 millions

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales

Event Calendar
SPLS's Profile
Stock Price
SPLS's Financials
SPLS's Expectations
Business Description
Charts & Quotes
SPLS's News
SPLS's Competitors
Customers & Markets
Economic Indicators
SPLS's Growth
Company Segments

At a Glance
Growth Rates
Financial Strength

At a Glance
Sectors & Industries

Stock Performance
Growth Rates
Financial Strength
Management Effectivness

At a Glance

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms

About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com